BTI
ATHE

Blue Trust Inc’s Alterity Therapeutics ATHE Stock Holding History

Blue Trust Inc’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215 Hold
40
– – ﹤0.01% 2392
2026
Q1 		$139 Hold
40
– – ﹤0.01% 2436
2025
Q4 		$123 Hold
40
– – ﹤0.01% 2495
2025
Q3 		$150 Hold
40
– – ﹤0.01% 2523
2025
Q2 		$164 Hold
40
– – ﹤0.01% 2391
2025
Q1 		$138 Hold
40
– – ﹤0.01% 2437
2024
Q4 		$132 Hold
40
– – ﹤0.01% 2395
2024
Q3 		$72 Buy
+40
New +$59 ﹤0.01% 2880

Other funds holding ATHE

TLCM
Twin Lakes Capital Management Redwood Shores, California $262M AUM 60.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Blue Trust Inc's ATHE Position: Q2 2026 in Review

Blue Trust Inc held its Alterity Therapeutics (ATHE) position steady in Q2 2026 at 40 shares worth $215. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

Blue Trust Inc first reported a position in ATHE in Q3 2024 and has held it in 8 quarters since. 22 funds tracked by Wall St. Rank hold ATHE as of Q2 2026.

  • Blue Trust Inc held 40 shares of Alterity Therapeutics worth $215 as of Q2 2026.
  • Blue Trust Inc left its Alterity Therapeutics share count unchanged in Q2 2026.
  • Alterity Therapeutics made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2392 holding.
  • Blue Trust Inc first reported a position in Alterity Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 22 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.